901 results on '"Filho JS"'
Search Results
2. Variability of endometrial glandular opening count in infertile patients prior to first IVF treatment
3. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
4. Abstract P3-06-08: Mucinous and neuroendocrine breast cancers: A spectrum of genetically-related lesions distinct from common forms of estrogen receptor-positive breast cancers
5. Abstract P3-07-02: Metaplastic breast carcinomas and uterine carcinosarcomas are histologically and genetically related
6. Abstract P1-06-08: A p53-independent DNA damage response that regulates breast cancer phenotypes
7. Abstract P3-06-07: Recurrent but not pathognomonic fusion genes in mucinous carcinomas of the breast
8. Abstract P2-01-02: Whole exome sequencing analysis of the progression from ductal carcinomain situto invasive ductal carcinoma
9. Abstract P4-04-01: The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
10. Abstract PD8-09: Bi-allelic alterations in homologous recombination (HR) DNA repair-related genes as the basis for HR defects in human cancers: A pan-cancer genomics and functional analysis
11. Abstract GS2-01: Discovery and characterization of an estrogen bound LncRNA in late-Stage breast cancer
12. Abstract P2-05-08: Mucinous breast carcinomas: A genomically distinct subtype of estrogen receptor-positive invasive breast cancers
13. Abstract PD4-13: Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis
14. Abstract PD1-15: The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers
15. Abstract P2-05-03: Novel driver genetic alterations in MYB-NFIB-negative breast adenoid cystic carcinomas
16. An introduction to genes, genomes and disease
17. Abstract P1-05-04: Intra-tumor genetic heterogeneity and histologic heterogeneity within metaplastic breast cancers: Genotypic-phenotypic correlations
18. Abstract P2-04-16: CD103+/PD-1+ T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition
19. Abstract P1-05-03: The genomic landscape of breast metaplastic carcinoma
20. Abstract S2-02: The landscape of somatic genetic alterations in BRCA1 and BRCA2 breast cancers
21. Abstract P1-07-06: Immune signatures define and affect prognosis in triple-negative breast cancer subtypes
22. Ependimomas: achados clínicos, epidemiológicos e anatomopatológicos de 22 casos
23. Abstract P2-01-02: Capturing intra-tumor genetic heterogeneity in cell-free plasma DNA from patients with oligometastatic breast cancer
24. Abstract P6-03-10: Genomic and transcriptomic heterogeneity in metaplastic breast carcinomas
25. Abstract P2-08-08: Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis
26. Abstract P6-07-04: Distinct repertoires of somatic mutations affecting driver genes in mucinous and neuroendocrine carcinomas of the breast
27. Abstract S4-04: Lobular carcinoma in situ displays intra-lesion genetic heterogeneity and its progression to invasive disease involves clonal selection and variations in mutational processes
28. Abstract P6-06-02: Germline CDH1 mutations in lobular carcinoma in situ
29. Abstract P2-05-01: Single cell sequencing analysis of formalin-fixed paraffin-embedded ductal carcinomas in situ and invasive breast cancers reveals clonal selection in the progression from in situ to invasive disease
30. Abstract S4-03: A functional assay for homologous recombination (HR) DNA repair and whole exome sequencing reveal that HR-defective sporadic breast cancers are enriched for genetic alterations in DNA repair genes
31. Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis
32. Molecular alterations of PDGA and PDGFRA in Gliomas
33. Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis
34. Abstract S4-02: Integrated genomic analyses of members of protein kinase C family identifies subtype specific alterations as novel therapeutic targets
35. Abstract PD4-5: Longitudinal massively parallel sequencing analysis of circulating cell-free tumor DNA: A feasibility study
36. Abstract S6-06: High-depth massively parallel sequencing reveals heterogeneity between primary tumor and metastatic deposits in de novo metastatic breast cancer patients prior to exposure to systemic therapy
37. Abstract P4-05-15: Breast cancers with BRCA1 and BRCA2 mutations are associated with specific pathologic features and molecular profiles: Results from a TCGA sub-analysis
38. Abstract P4-04-05: Molecular subtyping reveals the heterogeneity of metaplastic breast cancers
39. Abstract P3-04-07: Functional BRCA-pathway defects in sporadic breast cancers rarely show a significant reduction in BRCA-pathway proteins
40. Abstract P4-04-08: Genomic and transcriptomic characterization of papillary carcinomas of the breast
41. Abstract PD05-08: Genomic characterisation of invasive breast cancers with heterogeneous HER2 gene amplification
42. P1-06-22: Identification of Biomarkers in Breast Cancer for Prediction of Response to PARP Inhibitor Olaparib.
43. P1-06-14: Topoisomerase II alpha (Top2a) Protein Expression Is a Predictor for Response to Anthracycline-Based Chemotherapy (ATC-CT): Is It Due to Gene Amplification, HER2−Coamplification or a Summation of Pathways Leading to This Highly Proliferative Phenotype?
44. Interpretation and molecular validation of biomarker studies
45. Preclinical evaluation of the PARP-inhibitor olaparib for the treatment of ovarian clear cell cancer
46. Abstract P4-02-03: Gene Copy Number Alterations Related to mRNA and miRNA Expression in Endocrine Resistant Breast Cancers
47. Abstract ES4-2: The importance of Technical Validation
48. Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
49. ESR1amplification in endometrial carcinomas: hope or hyperbole?
50. The genomic profile of HER2 ‐amplified breast cancers: the influence of ER status
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.